Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma

Thrombosis Research

Volumn 126, Issue 6, 2010, Pages 477-480

  Lekovic, Danijela ^a   Miljic, Predrag ^a   Mihaljevic, Biljana ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Non Hodgkin's lymphoma; Primary mediastinal large B cell lymphoma; Venous thromboembolism

Indexed keywords

BLEOMYCIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CYCLOPHOSPHAMIDE; D DIMER; DOXORUBICIN; ETOPOSIDE; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE; WARFARIN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; LARGE CELL LYMPHOMA; LUNG EMBOLISM; MALE; MEDIASTINUM TUMOR; MEDICAL RECORD REVIEW; PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SUPERIOR CAVA VEIN SYNDROME; SURVIVAL; SURVIVAL RATE; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT RESPONSE; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 78649750192     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.08.017     Document Type: Article

References (34)

1. J.T. Wiernikowski, and U.H. Athale Thromboembolic complications in children with cancer Thromb Res 118 2006 137 152
2. U.H. Athale, and A.K. Chan Thrombosis in children with acute lymphoblastic leukemia: Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia- Effects of the disease and therapy Thromb Res 111 2003 199 212
3. J.W. Blom, C.J. Doggen, and S. Osanto Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722 (Pubitemid 40216041)
4. R.J. Hettiarachchi, J. Lok, and M.H. Prins Undiagnosed malignancy in patients with deep vein thrombosis: Incidence, risk indicators, and diagnosis Cancer 83 1998 180 185
5. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: Risks and outcomes Circulation 107 2003 I17 I21
6. M. Di Nisio, H.M. Otten, and A. Piccioli Decision analysis for cancer screening in idiopathic venous thromboembolism J Thromb Haemost 3 2005 2391 2396
7. M. Monreal, A.W. Lensing, and M.H. Prins Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism J Thromb Haemost 2 2004 876 881
8. A. Piccioli, A.W. Lensing, and M.H. Prins Extensive screening for occult malignant disease in idiopathic venous thromboembolism: A prospective randomized clinical trial J Thromb Haemost 2 2004 884 889
9. A. Rance, J. Emmerich, and C. Guedj Occult cancer in patients with bilateral deep-vein thrombosis Lancet 350 1997 1448 1449
10. F.R. Rickles, and M.N. Levine Epidemiology of thrombosis in cancer Acta Haematol 106 2001 6 12
11. H.I. Saba, F.K. Khalil, and G.A. Morelli Thromboembolism preceding cancer: A correlation study Am J Hematol 72 2003 109 114
12. V.S. Shen, and E.W. Pollak Fatal pulmonary embolism in cancer patients: Is heparin prophylaxis justi- fied? South Med J 73 1980 841 843
13. H.T. Sorensen, L. Mellemkjaer, and F.H. Steffensen The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism N Engl J Med 338 1998 1169 1173
14. H.T. Sorensen, L. Mellemkjaer, and J.H. Olsen Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850
15. P. Prandoni, A. Falanga, and A. Piccioli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410
16. M.B. Donati, and A. Falanga Pathogenetic mechanisms of thrombosis in malignancy Acta Haematol 106 2001 18 24
17. A. Falanga, and M.B. Donati Pathogenesis of thrombosis in patients with malignancy Int J Hematol 73 2001 137 144
18. A. Falanga, M. Marchetti, and A. Vignoli Clotting mechanisms and cancer: Implications in thrombus formation and tumor progression Clin Adv Hematol Oncol 1 2003 673 678
19. M.N. Levine, M. Gent, and J. Hirsh The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N Engl J Med 318 1988 404 407
20. R.S. Komrokji, N.P. Uppal, and A.A. Khorana Venous thromboembolism in patients with diffuse large B-cell lymphoma Leuk Lymphoma 47 2006 1029 1033
21. B.J. Addis, and P.G. Isaacson Large cell lymphoma of the mediastinum: A B-cell tumour of probable thymic origin Histopathology 10 1986 379 390
22. J.B. Miller, D. Variakojis, and J.D. Bitran Diffuse histiocytic lymphoma with sclerosis: A clinicopathologic entity frequently causing superior venacaval obstruction Cancer 47 1981 748 756
23. M. Lazzarino, E. Orlandi, and M. Paulli Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features J Clin Oncol 11 1993 2306 2313
24. J.T. Brandt, L.K. Barna, and D.A. Triplett Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH Thromb Haemost 74 1995 1597 1603
25. E.J. Seifter, R.C. Young, and D.L. Longo Deep venous thrombosis during therapy for Hodgkin's disease Cancer Treat Rep 69 1995 1011 1013
26. N. Goldschmidt, E. Linetsky, and E. Shalom High incidence of thromboembolism in patients with central nervous system lymphoma Cancer 98 2003 1239 1242
27. M. Mohren, I. Markmann, and K. Jentsch-Ullrich Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis Br J Cancer 92 2005 1349 1351
28. H. Ottinger, C. Belka, and G. Kozole Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance Eur J Haematol 54 1995 186 194
29. P. Shivakumar, R. Anderson, and S. Couban Catheter associated thrombosis in patients with malignancy J Clin Oncol 27 2009 4858 4864
30. M. Gallieni, M. Pittiruti, and R. Biffi Vascular access in oncology patients CA Cancer J Clin 58 2008 323 346
31. A. Khorana, and G. Connolly Assessing risk of venous thromboembolism in the patient with cancer J Clin Oncol 27 2009 4839 4847
32. N. Levitan, A. Dowlati, and S.C. Remick Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 1999 285 291
33. A.Y. Lee, M.N. Levine, and R.I. Baker Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146 153
34. H.T. Sorensen, L. Mellemkjaer, and J.H. Olsen Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850